Propanc Biopharma, Inc.
PPCBNasdaqCIK 1517681HealthcareFiscal year ends Jun 30
Reports and events: 233 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-09-1717:44 ET | 10-K | Annual reportPeriod 2018-06-30 | 0001493152-18-013392 |
| 2018-09-0716:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-012996 |
| 2018-09-0417:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-012880 |
| 2018-07-1916:52 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-010209 |
| 2018-07-0616:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-009759 |
| 2018-07-0217:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-009567 |
| 2018-06-2016:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-009028 |
| 2018-05-1017:23 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001493152-18-006584 |
| 2018-04-1916:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-005490 |
| 2018-04-1008:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-004966 |
| 2018-03-2917:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-004181 |
| 2018-03-2217:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-18-003761 |
| 2018-03-1408:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-003311 |
| 2018-02-2008:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-18-002328 |
| 2018-02-0920:58 ET | 10-Q | Quarterly reportPeriod 2017-12-31 | 0001493152-18-001696 |
| 2018-01-2616:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-18-001103 |
| 2018-01-0517:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-000246 |
| 2017-11-0917:03 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001493152-17-012713 |
| 2017-10-0208:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-17-011112 |
| 2017-09-2816:22 ET | 10-K | Annual reportPeriod 2017-06-30 | 0001493152-17-011027 |
| 2017-08-1517:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-17-009458 |
| 2017-07-2817:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-17-008254 |
| 2017-06-0116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-17-006074 |
| 2017-05-0817:30 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001493152-17-004870 |
| 2017-04-2616:51 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-17-004418 |
| 2017-04-0509:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-17-003513 |
| 2017-03-3116:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-018180 |
| 2017-03-2109:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-015718 |
| 2017-02-2309:01 ET | 8-K | 5.07 Shareholder vote results | 0001144204-17-010511 |
| 2017-02-1412:58 ET | 10-Q | Quarterly reportPeriod 2016-12-31 | 0001144204-17-008493 |
| 2017-02-0316:34 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-17-005927 |
| 2016-12-3016:21 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-16-141934 |
| 2016-12-0717:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-16-138410 |
| 2016-11-2311:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-16-136198 |
| 2016-11-1017:29 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001144204-16-133411 |
| 2016-09-2817:24 ET | 10-K | Annual reportPeriod 2016-06-30 | 0001144204-16-125808 |
| 2016-09-1616:34 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-16-124270 |
| 2016-08-2316:14 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-120760 |
| 2016-08-1916:32 ET | S-1 | Registration statement | 0001144204-16-120372 |
| 2016-08-0421:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-16-116371 |
| 2016-07-0517:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-111538 |
| 2016-05-2416:40 ET | 8-K | 8.01 Other events | 0001144204-16-104526 |
| 2016-05-1613:54 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001144204-16-102344 |
| 2016-04-1410:15 ET | S-1/A | Registration statement, amended | 0001144204-16-094251 |
| 2016-03-2518:35 ET | S-1 | Registration statement | 0001144204-16-090186 |
| 2016-03-1117:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-16-087613 |
| 2016-02-1613:09 ET | 10-Q | Quarterly reportPeriod 2015-12-31 | 0001144204-16-082302 |
| 2015-12-1010:21 ET | S-1/A | Registration statement, amended | 0001144204-15-070249 |
| 2015-11-2312:01 ET | S-1 | Registration statement | 0001144204-15-067435 |
| 2015-11-1712:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-066313 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.